Compare DexCom, Inc. (DXCM) vs Harley-Davidson Inc (HOG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Harley-Davidson Inc — how do they compare? DexCom, Inc. trades at $77.28 (market cap $28.06B), while Harley-Davidson Inc trades at $26.62 (market cap $2.73B). The key difference: DexCom, Inc. is far larger — about 10.3× Harley-Davidson Inc's market cap, and Harley-Davidson Inc pays a 2.83% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | HOG | |
|---|---|---|
Market Cap | $28.06B | $2.73B |
Sector | Health | Consumer Cyclical |
52-Week High | $89.53 | $31.03 |
52-Week Low | $54.84 | $17.19 |
Enterprise Value | $27.03B | $3.13B |
Dividend Yield | — | 2.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
Harley-Davidson (HOG) trades at $26.67, up 6.21% over the past day, with technical indicators showing a bullish trend. The stock is fundamentally supported by attractive valuation ratios, including a P/E of 13.45 and P/B of 0.89, but faces declining revenue and net income margins. Recent news highlights the company's strategic moves, such as bringing Revolution Max engine production back to the U.S. and upcoming Q2 2026 earnings on July 23, 2026.
The outlook is mixed: cost-cutting initiatives and production shifts may support margins, but earnings misses and competitive pressures pose risks. Analyst consensus is cautious with a hold-heavy rating and a price target of $23.40, below the current price, indicating limited near-term upside potential amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Harley-Davidson Inc
Harley-Davidson is a global leading manufacturer of heavyweight motorcycles, merchandise, parts, and accessories. It sells custom, cruiser, and touring motorcycles and offers a complete line of Harley-Davidson motorcycle parts, accessories, riding gear, and apparel, as well as merchandise. Harley-Davidson Financial Services provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley has historically captured about half of all heavyweight domestic retail motorcycle registrations, a metric it had ceded in 2020 as it repositioned the business, but a level it is working back toward. In recent years the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand.
Read more on HOG →
